Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry

To evaluate the impact of rituximab on patient-reported outcomes (PROs) in a US-based observational cohort of patients with rheumatoid arthritis (RA). Patients with active RA, prior exposure to ≥1 tumor necrosis factor inhibitor (TNFi) and who newly initiated rituximab were identified. Changes in PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrold, Leslie R., John, Ani, Best, Jennie, Zlotnick, Steve, Karki, Chitra, Li, YouFu, Greenberg, Jeffrey D., Kremer, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554472/
https://www.ncbi.nlm.nih.gov/pubmed/28718043
http://dx.doi.org/10.1007/s10067-017-3742-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554472/
https://www.ncbi.nlm.nih.gov/pubmed/28718043
http://dx.doi.org/10.1007/s10067-017-3742-2

Ejemplares similares